Acute Kidney Injury in Patients Using Amikacin in Intensive Care Unit-A Paired Case-Control Study With Meropenem

Am J Ther. 2020 Jul/Aug;27(4):e403-e405. doi: 10.1097/MJT.0000000000000955.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Amikacin / adverse effects*
  • Amikacin / therapeutic use
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenem-Resistant Enterobacteriaceae
  • Case-Control Studies
  • Dose-Response Relationship, Drug
  • Enterobacteriaceae Infections / drug therapy
  • Female
  • Humans
  • Incidence
  • Intensive Care Units / statistics & numerical data*
  • Male
  • Meropenem / adverse effects*
  • Meropenem / therapeutic use
  • Risk Factors
  • Severity of Illness Index
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin
  • Amikacin
  • Meropenem